Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trial [0.03%]
维生素D3对临床孤立综合征和健康对照参与者的影响：一项双盲随机对照试验
Karen O&#x;Connell,Jamal Sulaimani,Sharee A Basdeo et al.
Karen O&#x;Connell et al.
Background: Lowserum vitamin D levels are associated with susceptibility to, and severity of, multiple sclerosis. High dose vitamin D has been proposed as a potential immunomodulator in multiple sclerosis. ...
Healthcare expenditure of multiple sclerosis patients in 2013: A nationwide study based on French health administrative databases [0.03%]
2013年法国多发性硬化症患者的卫生保健支出：基于法国健康行政数据库的全国性研究
Delphine Lefeuvre,Jérémie Rudant,Stéphanie Foulon et al.
Delphine Lefeuvre et al.
Background: Little is known about expenditure items of multiple sclerosis (MS) patients over recent years in France. Objective: To desc...
Quantitative characterization of optic nerve atrophy in patients with multiple sclerosis [0.03%]
多发性硬化患者的视神经萎缩的定量特征分析
Robert L Harrigan,Alex K Smith,Bailey Lyttle et al.
Robert L Harrigan et al.
Background: Optic neuritis (ON) is one of the most common presentations of multiple sclerosis (MS). Magnetic resonance imaging (MRI) of the optic nerves is challenging because of retrobulbar motion, orbital fat and suscep...
Serum retinol levels are associated with brain volume loss in patients with multiple sclerosis [0.03%]
血清视黄醇水平与多发性硬化患者脑容量丢失有关
H Yokote,T Kamata,S Toru et al.
H Yokote et al.
Background: Although predicting future brain volume loss (BVL) in patients with multiple sclerosis (MS) is important, studies have shown only a few biomarkers that can predict BVL. ...
Which symptoms contribute the most to patients' perception of health in multiple sclerosis? [0.03%]
哪些症状最影响多发性硬化患者的健康感知？
Rivka Green,Gary Cutter,Michael Friendly et al.
Rivka Green et al.
Background: Multiple sclerosis is a polysymptomatic disease. Little is known about relative contributions of the different multiple sclerosis symptoms to self-perception of health. ...
Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up [0.03%]
在临床实践中的疗效和停药比较：二甲基呋喃酸酯与芬戈莫德两年的随访结果分析
Carrie M Hersh,Thomas E Love,Anasua Bandyopadhyay et al.
Carrie M Hersh et al.
Background: Dimethyl fumarate and fingolimod are oral disease-modifying therapies approved to treat relapsing multiple sclerosis. Prior observational studies and our previous 12-month investigation showed comparable clini...
Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis [0.03%]
早期多发性硬化症患者血清netrin-1与钆增强磁共振成像的关系
M M Voortman,T Pekar,D Bachmayer et al.
M M Voortman et al.
Background: Netrin-1, a secreted laminin-related protein, is known to regulate not only axonal guidance and neuronal cell migration, but also blood-brain barrier integrity and inflammation. Two preliminary studies reporte...
Application of the Betty Neuman systems model in the nursing care of patients/clients with multiple sclerosis [0.03%]
贝蒂·纽曼系统模型在多发性硬化患者护理中的应用研究
Zakieh Ahmadi,Tabandeh Sadeghi
Zakieh Ahmadi
Objective: This study aimed to assess the application of the Betty Neuman systems model to the care of patient/clients with multiple sclerosis. Methods: ...
Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience [0.03%]
芬戈莫德与富马酸二甲酯治疗多发性硬化症的比较：两年期研究经验总结
Brandi Vollmer,Kavita V Nair,Stefan H Sillau et al.
Brandi Vollmer et al.
Background: Fingolimod (FTY) and dimethyl fumarate (DMF) are multiple sclerosis (MS) oral therapies that became available in 2010 and 2013, respectively. ...
Finger and foot tapping as alternative outcomes of upper and lower extremity function in multiple sclerosis [0.03%]
多发性硬化症上肢和下肢功能的替代结果：手指和脚趾敲击
Makoto Tanigawa,Jason Stein,John Park et al.
Makoto Tanigawa et al.
Background: While magnetic resonance imaging contrast-enhancing lesions represent an excellent screening tool for disease-modifying treatments in relapsing-remitting multiple sclerosis (RRMS), this biomarker is insensitiv...